TLR4/PKCα/occludin signaling pathway may be related to blood‑brain barrier damage

Tang,Zhixian; Guo,Dan; Xiong,Liang; Wu,Bing; Xu,Xuehua; Fu,Jinfeng; Kong,Liyun; Liu,Ziyou; Xie,Chunfa

doi:10.3892/mmr.2018.9025

TLR4/PKCα/occludin signaling pathway may be related to blood‑brain barrier damage

Authors:
- Zhixian Tang
- Dan Guo
- Liang Xiong
- Bing Wu
- Xuehua Xu
- Jinfeng Fu
- Liyun Kong
- Ziyou Liu
- Chunfa Xie
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, Heart Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China, Department of Histology and Embryology, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China, Department of Preventive Medicine, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China, Department of Anatomy, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China, Department of Operation Room, Heart Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China
Published online on: May 16, 2018 https://doi.org/10.3892/mmr.2018.9025
Pages: 1051-1057

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Abnormal blood-brain barrier (BBB) is a common pathological feature in brain damage. In the present study, a brain microvascular endothelial cell (BMEC) model was established to determine the role of the toll‑like receptor 4 (TLR4)/protein kinase Cα (PKCα)/occludin signaling pathway in BBB dysfunction. Three small interfering (si)RNAs directed against PKCα were designed to investigate the molecular mechanisms of PKCα underlying BBB damage. BMECs were divided into 4 groups: Control group, TAK‑242 (a TLR4 inhibitor) group, PKCα‑siRNA group and TAK‑242+PKCα‑siRNA group. The results indicated that siRNA‑3 was the most effective at silencing PKCα gene expression. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) analysis indicated no significant difference of TLR4 mRNA expression levels between three different treated groups and the Control group. However, PKCα mRNA expression in the PKCα‑siRNA and TAK‑242+PKCα‑siRNA groups were significantly decreased compared with that in Control and TAK‑242 groups. In addition, occludin mRNA expression in PKCα‑siRNA and TAK‑242+PKCα‑siRNA groups were significantly higher compared with the Control group. Meanwhile, occluding expressions in three treated groups were also significantly higher compared with the Control group. Furthermore, TAK‑242 treatment, PKCα‑siRNA treatment, and TAK‑242+PKCα‑siRNA treatment could promote occludin junctional labeling compared with the Control group. The permeability of PKCα‑siRNA and TAK‑242+PKCα‑siRNA groups was significantly promoted compared with the control group. The TLR4/PKCα/occludin signaling pathway was closely related to BBB damage. The present study will lead to an improved molecular understanding of BBB damage in the future.

View Figures

View References

1	Griepp RB, Stinson EB, Hollingsworth JF and Buehler D: Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg. 70:1051–1063. 1975.PubMed/NCBI
2	Wypij D, Newburger JW, Rappaport LA, duPlessis AJ, Jonas RA, Wernovsky G, Lin M and Bellinger DC: The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: The boston circulatory arrest trial. J Thorac Cardiovasc Surg. 126:1397–1403. 2003. View Article : Google Scholar : PubMed/NCBI
3	Ronaldson PT and Davis TP: Blood-brain barrier integrity and glial support: Mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des. 18:3624–3644. 2012. View Article : Google Scholar : PubMed/NCBI
4	Liu WY, Wang ZB, Zhang LC, Wei X and Li L: Tight junction in blood-brain barrier: An overview of structure, regulation, and regulator substances. CNS Neurosci Ther. 18:609–615. 2012. View Article : Google Scholar : PubMed/NCBI
5	Shin K, Fogg VC and Margolis B: Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 22:207–235. 2006. View Article : Google Scholar : PubMed/NCBI
6	Fanning AS and Anderson JM: Zonula occludens-1 and −2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann N Y Acad Sci. 1165:113–120. 2009. View Article : Google Scholar : PubMed/NCBI
7	Runkle EA and Mu D: Tight junction proteins: From barrier to tumorigenesis. Cancer Lett. 337:41–48. 2013. View Article : Google Scholar : PubMed/NCBI
8	Minagar A, Maghzi AH, McGee JC and Alexander JS: Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy. Neurol Res. 34:738–745. 2012. View Article : Google Scholar : PubMed/NCBI
9	Cummins PM: Occludin: One protein, many forms. Mol Cell Biol. 32:242–250. 2012. View Article : Google Scholar : PubMed/NCBI
10	Gerber J, Heinrich J and Brehm R: Blood-testis barrier and Sertoli cell function: Lessons from SCCx43KO mice. Reproduction. 151:R15–R27. 2016. View Article : Google Scholar : PubMed/NCBI
11	Capaldo CT and Nusrat A: Cytokine regulation of tight junctions. Biochim Biophys Acta. 1788:864–871. 2009. View Article : Google Scholar : PubMed/NCBI
12	Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J and Blasig IE: Structure and function of claudins. Biochim Biophys Acta. 1778:631–645. 2008. View Article : Google Scholar : PubMed/NCBI
13	Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA and Malik AB: PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity. Circ Res. 111:739–749. 2012. View Article : Google Scholar : PubMed/NCBI
14	Singh I, Knezevic N, Ahmmed GU, Kini V, Malik AB and Mehta D: Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Chem. 282:7833–7843. 2007. View Article : Google Scholar : PubMed/NCBI
15	Hutchinson TE, Zhang J, Xia SL, Kuchibhotla S, Block ER and Patel JM: Enhanced phosphorylation of caveolar PKC-α limits peptide internalization in lung endothelial cells. Mol Cell Biochem. 360:309–320. 2012. View Article : Google Scholar : PubMed/NCBI
16	Alonso A and Gonzalez C: Neuroprotective role of estrogens: Relationship with insulin/IGF-1 signaling. Front Biosci (Elite Ed). 4:607–619. 2012. View Article : Google Scholar : PubMed/NCBI
17	Melkamu T, Squillace D, Kita H and O'Grady SM: Regulation of TLR2 expression and function in human airway epithelial cells. J Membr Biol. 229:101–113. 2009. View Article : Google Scholar : PubMed/NCBI
18	Su W, Mruk DD and Cheng CY: Regulation of actin dynamics and protein trafficking during spermatogenesis-insights into a complex process. Crit Rev Biochem Mol Biol. 48:153–172. 2013. View Article : Google Scholar : PubMed/NCBI
19	Cuschieri J, Billigren J and Maier RV: Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: A condition reversed by PKC activation. J Leukoc Biol. 80:1289–1297. 2006. View Article : Google Scholar : PubMed/NCBI
20	Li X, Wang C, Nie J, Lv D, Wang T and Xu Y: Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis. Alcohol. 47:459–465. 2013. View Article : Google Scholar : PubMed/NCBI
21	Peng Y, Sigua CA, Rideout D and Murr MM: Deletion of toll-like receptor-4 downregulates protein kinase C-zeta and attenuates liver injury in experimental pancreatitis. Surgery. 143:679–685. 2008. View Article : Google Scholar : PubMed/NCBI
22	Zhang Y, Chen H and Yang L: Toll-like receptor 4 participates in gastric mucosal protection through Cox-2 and PGE2. Dig Liver Dis. 42:472–476. 2010. View Article : Google Scholar : PubMed/NCBI
23	Molnár K, Vannay A, Szebeni B, Bánki NF, Sziksz E, Cseh A, Győrffy H, Lakatos PL, Papp M, Arató A and Veres G: Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease. World J Gastroenterol. 18:3254–3259. 2012.PubMed/NCBI
24	Eun CS, Han DS, Lee SH, Paik CH, Chung YW, Lee J and Hahm JS: Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: Effect on Toll-like receptor pathway. Dig Dis Sci. 51:693–697. 2006. View Article : Google Scholar : PubMed/NCBI
25	Rigor RR, Beard RS Jr, Litovka OP and Yuan SY: Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium. Am J Physiol Cell Physiol. 302:C1513–C1522. 2012. View Article : Google Scholar : PubMed/NCBI
26	Naik P and Cucullo L: In vitro blood-brain barrier models: Current and perspective technologies. J Pharm Sci. 101:1337–1354. 2012. View Article : Google Scholar : PubMed/NCBI
27	Irie N, Sakai N, Ueyama T, Kajimoto T, Shirai Y and Saito N: Subtype- and species-specific knockdown of PKC using short interfering RNA. Biochem Biophys Res Commun. 298:738–743. 2002. View Article : Google Scholar : PubMed/NCBI
28	Chen C, Mei H, Shi W, Deng J, Zhang B, Guo T, Wang H and Hu Y: EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS One. 8:e608602013. View Article : Google Scholar : PubMed/NCBI
29	Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T and Iizawa Y: A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol. 69:1288–1295. 2006. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
31	Daneman R: The blood-brain barrier in health and disease. Ann Neurol. 72:648–672. 2012. View Article : Google Scholar : PubMed/NCBI
32	You K, Xu X, Fu J, Xu S, Yue X, Yu Z and Xue X: Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1. Respir Res. 13:362012. View Article : Google Scholar : PubMed/NCBI
33	Fleegal MA, Hom S, Borg LK and Davis TP: Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol. 289:H2012–H2019. 2005. View Article : Google Scholar : PubMed/NCBI
34	Willis CL, Meske DS and Davis TP: Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab. 30:1847–1859. 2010. View Article : Google Scholar : PubMed/NCBI
35	Lameris AL, Huybers S, Kaukinen K, Mäkelä TH, Bindels RJ, Hoenderop JG and Nevalainen PI: Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease. Scand J Gastroenterol. 48:58–69. 2013. View Article : Google Scholar : PubMed/NCBI
36	dela Paz NG, Walshe TE, Leach LL, Saint-Geniez M and D'Amore PA: Role of shear-stress-induced VEGF expression in endothelial cell survival. J Cell Sci. 125:831–843. 2012. View Article : Google Scholar : PubMed/NCBI
37	Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, et al: Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell. 24:3056–3068. 2013. View Article : Google Scholar : PubMed/NCBI
38	Schmidt E, Kelly SM and van der Walle CF: Tight junction modulation and biochemical characterisation of the zonula occludens toxin C-and N-termini. FEBS Lett. 581:2974–2980. 2007. View Article : Google Scholar : PubMed/NCBI
39	Lee WL and Liles WC: Endothelial activation, dysfunction and permeability during severe infections. Curr Opin Hematol. 18:191–196. 2011. View Article : Google Scholar : PubMed/NCBI
40	Speyer CL and Ward PA: Role of endothelial chemokines and their receptors during inflammation. J Invest Surg. 24:18–27. 2011. View Article : Google Scholar : PubMed/NCBI
41	Lamalice L, Le Boeuf F and Huot J: Endothelial cell migration during angiogenesis. Circ Res. 100:782–794. 2007. View Article : Google Scholar : PubMed/NCBI
42	Tremblay PL, Auger FA and Huot J: Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene. 25:6563–6573. 2006. View Article : Google Scholar : PubMed/NCBI
43	Schulz E, Gori T and Munzel T: Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 34:665–673. 2011. View Article : Google Scholar : PubMed/NCBI
44	Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM and Roy NC: Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 141:769–776. 2011. View Article : Google Scholar : PubMed/NCBI
45	González-Mariscal L, Tapia R and Chamorro D: Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta. 1778:729–756. 2008. View Article : Google Scholar : PubMed/NCBI
46	Wardill HR, Gibson RJ, Logan RM and Bowen JM: TLR4/PKC-mediated tight junction modulation: A clinical marker of chemotherapy-induced gut toxicity? Int J Cancer. 135:2483–2792. 2014. View Article : Google Scholar : PubMed/NCBI
47	Matsunaga N, Tsuchimori N, Matsumoto T and Ii M: TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol. 79:34–41. 2011. View Article : Google Scholar : PubMed/NCBI